آخرین اخبار
Archive
Complex Thyroid Cases Discussed at the Monthly Conference of the Endocrinology Research Institute
Sep 7 2026
Complex Thyroid Cases Discussed at the Monthly Conference of the Endocrinology Research Institute
At the monthly thyroid conference of the Endocrinology Research Institute, two challenging clinical cases—including bone metastasis of follicular thyroid carcinoma and synchronous medullary and papillary thyroid carcinoma—were presented by Dr. Naghmeh Habibi, and optimal treatment strategies were discussed.
Achieving Normal Thyroid Function Before Pregnancy The Key to Reducing Maternal and Fetal Complications by Up to 70%
Aug 24 2026
Achieving Normal Thyroid Function Before Pregnancy The Key to Reducing Maternal and Fetal Complications by Up to 70%
At the Weekly Conference of the Endocrinology and Metabolism Research Institute, the latest clinical guidelines of the American Thyroid Association (ATA) on the management of hyperthyroidism during pregnancy were reviewed. According to these guidelines, achieving euthyroidism (normal thyroid function) before conception is the cornerstone for reducing maternal and fetal complications. It was also emphasized that propylthiouracil (PTU) is the preferred treatment during the first trimester due to its lower risk of congenital malformations, and that measurement of TRAb/TSI antibodies plays a pivotal role in predicting disease relapse and monitoring fetal thyrotoxicosis.
From Heart to Liver: Novel Diabetes Drugs Offer Dual Wings of Protection for High-Risk Patients
Aug 18 2026
From Heart to Liver: Novel Diabetes Drugs Offer Dual Wings of Protection for High-Risk Patients
At the weekly Journal Club of the Endocrinology and Metabolism Research Institute, a comprehensive meta-analysis encompassing over 5.3 million diabetic patients was reviewed. The findings, presented in a PDF file, demonstrate that GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors not only improve glycemic control and cardiovascular outcomes but also significantly reduce the risk of hepatocellular carcinoma (HCC) and non-HCC liver-related events. In contrast, DPP-4 inhibitors were associated with an increased risk of non-HCC liver-related complications. The session was well-received by faculty members and students alike.
Three Complex Cases of Papillary Thyroid Cancer Discussed at the Monthly Thyroid Conference of the Research Institute
Aug 5 2026
Three Complex Cases of Papillary Thyroid Cancer Discussed at the Monthly Thyroid Conference of the Research Institute
The monthly Thyroid Conference of the Endocrine Research Institute was held on Monday, August 5, 2026, featuring three challenging clinical cases of patients with Papillary Thyroid Cancer (PTC) with pulmonary metastases and recurrent disease, presented by Dr. Naghme Habibi, an endocrinology subspecialist. The session covered the latest diagnostic and therapeutic approaches, including radioactive iodine therapy, re-operation, targeted therapies such as Lenvatinib, and the importance of a multidisciplinary approach in managing these conditions.
Monthly Pituitary Meeting Held at the Endocrinology Research Institute with Focus on Resistant Tumors and Diagnostic Challenges
Jul 29 2026
Monthly Pituitary Meeting Held at the Endocrinology Research Institute with Focus on Resistant Tumors and Diagnostic Challenges
The Monthly Pituitary Meeting of the Endocrinology and Metabolism Research Institute was held on Monday, July 27, 2026, with the attendance of faculty members, students, and specialists in pathology, radiology, and nuclear medicine. At this session, Dr. Zahra Noori, an endocrinology and metabolism subspecialist, presented three complex clinical cases including resistant prolactinoma, silent corticotroph adenoma, and pituitary incidentaloma, and elaborated on the latest international guidelines from leading global societies for managing these conditions.
Thyroid Cancer Seminar
Pituitary tumor seminar
Template settings